ACR 2020: Ixekizumab in Patients with Psoriatic Arthritis
Ixekizumab (IXE) is a high affinity monoclonal antibody that selectively targets interleukin-17A....
Read MoreDec 23, 2020
Ixekizumab (IXE) is a high affinity monoclonal antibody that selectively targets interleukin-17A....
Read MoreDec 23, 2020
Physician’s Weekly spoke with first author Nicholas A. Marston, MD, an Associate Physician in the Cardiovascular Division at Brigham and Women’s Hospital (Boston, USA), an Instructor of Medicine at Harvard Medical School, and an...
Read MoreDec 21, 2020
HBM9036 ophthalmic solution 0.25%, also known as tanfanercept, a novel TNF-α inhibitor, is safe and effective for improving certain symptoms of dry eye disease, according to results of a phase 2 randomized, a double-blind...
Read MoreDec 20, 2020
Dry eye disease (DED) is a highly prevalent syndrome that manifests with symptoms that include constant irritation, burning or stinging sensations, and feelings of grittiness in the eyes. “DED is a chronic pain syndrome often...
Read MoreDec 20, 2020
Previous research has shown that patients undergoing hematopoietic stem cell transplantation (HSCT) for hematologic malignancies, such as leukemia and lymphoma, are at a high risk of developing graft-versus-host disease (GVHD)....
Read MoreDec 20, 2020
Dry eye is a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance, and tear film instability. The disease can significantly decrease quality of life as it impacts an...
Read MoreDec 18, 2020
Acute side-effects of radiation therapy (RT) are often underrecognized by the physicians of...
Read MoreDec 18, 2020
An online tool (RSClin) incorporating clinical-pathologic data and results of the 21-gene...
Read MoreDec 18, 2020
Meeting Brief… A subgroup of patients participating in the randomized phase III NALA study...
Read MoreDec 18, 2020
The omission of radiotherapy (RT) does not affect overall survival at 10 years after breast...
Read MoreDec 18, 2020
Pregnancy is less likely after prior breast cancer (BC) diagnosis, according to a systematic...
Read MoreDec 15, 2020
MONDAY, Dec. 14, 2020 (HealthDay News) — Pregnancy is less likely after prior breast cancer...
Read MoreDec 11, 2020
Addition of selinexor to bortezomib and dexamethasone reduces neuropathy The triple combination of...
Read MoreDec 11, 2020
Projection shows increases by lines of therapy Physicians treating multiple myeloma can expect to...
Read MoreDec 10, 2020
HBM9036 ophthalmic solution 0.25%, also known as tanfanercept, a novel TNF-α inhibitor, is safe and effective for improving certain symptoms of dry eye disease, according to results of a phase 2 randomized, a double-blind...
Read MoreDec 10, 2020
Contributing to this article, Shahzad I. Mian, MD, Professor, Ophthalmology and Visual Sciences, Vice Chair, Clinical Sciences and Learning, Kellogg Eye Center, Michigan Medicine Previous research has shown that patients...
Read MoreDec 10, 2020
Reaching RAPID3 and cDAPSA Treatment Targets Linked with Active PsA Control in DMARD-naïve Patients Treated with Apremilast Disease-modifying anti-rheumatic drug (DMARD)-naïve patients achieving Routine Assessment of Patient...
Read MoreDec 10, 2020
Results from Phase 2 PoS Trial In patients with active psoriatic arthritis (PsA) , deucravacitinib was efficacious versus placebo (PBO) over 16 weeks of treatment. Treatment was well tolerated and the safety profile was...
Read MoreDec 9, 2020
New research was presented at FMX 2020, the 2020 American Academy of Family Physicians virtual...
Read MoreDec 4, 2020
The results of CONTESSA, a Phase 3 study of tesetaxel in the treatment of patients with metastatic breast cancer, have been selected for an oral presentation at the 2020 SABCS, to be held virtually December 8-11, 2020. The...
Read More